Atlas Trials

Generalized Pustular Psoriasis

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Generalized Pustular Psoriasis

RecordFirmDate
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (NCT05366855)Vanda Pharmaceuticals2022-04-21
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (NCT05352893)Vanda Pharmaceuticals2022-04-14
An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options (NCT05200247)Boehringer Ingelheim2022-02-17
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis (NCT04399837)Boehringer Ingelheim2020-06-04
A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis (NCT03942042)Eli Lilly and Company2019-07-05
Biologic Therapy for Generalized Pustular Psoriasis (NCT06391996)Chao Ji2019-07-01
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study (NCT03886246)LEO Pharma2019-05-29
Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis (NCT03782792)Boehringer Ingelheim2019-01-31
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis (NCT03619902)Vanda Pharmaceuticals2019-01-30
Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence (NCT04566471)Peking University Third Hospital2012-01-01

Track Generalized Pustular Psoriasis automatically

Every clearance here is in the API, with alerts when new ones post.